Torrent Pharma Inc Importer EIN 36-4547412 Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Torrent Pharma Inc Importer EIN 36-4547412 Pharmaceutical Import Records from India — 3 Products, $3.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Torrent Pharma Inc Importer EIN 36-4547412 — Pharmaceutical Importer Profile (2026) | 3 Products, $3.3M Trade | TransData Nexus

Torrent Pharma Inc Importer EIN 36-4547412

Pharmaceutical Importer · United States · CNS & Psychiatric Focus · $3.3M Total Trade · DGFT Verified

Torrent Pharma Inc Importer EIN 36-4547412 is a pharmaceutical importer based in United States with a total trade value of $3.3M across 3 products in 2 therapeutic categories. Based on 66 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Torrent Pharma Inc Importer EIN 36-4547412 sources from 1 verified Indian supplier, with Torrent Pharmaceuticals Limited accounting for 100.0% of imports.

Torrent Pharma Inc Importer EIN 36-4547412 — Import Portfolio & Supplier Network

Torrent Pharma Inc Importer EIN 36-4547412 import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Torrent Pharma Inc Importer EIN 36-4547412?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$3.4M	76	100.0%

Torrent Pharma Inc Importer EIN 36-4547412 sources from 1 verified Indian supplier across 27 distinct formulations. The sourcing is highly concentrated — Torrent Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Torrent Pharma Inc Importer EIN 36-4547412 Import?

Formulation	Value	Ships
Escitalopram tablets USP 20MG	$590.1K	12
Escitalopram tablets USP 10 MG	$367.4K	9
Minocycline hydrochloride capsules	$300.0K	6
Carbamazepine 200 MG tablets	$251.6K	6
Carbamazepine 200 MG USP	$200.0K	4
Carbamazepine tablets USP	$199.1K	5
Lamotrigine tablets USP 200MG	$168.6K	4
Escitalopram tablets USP 10MG	$150.0K	3
Citalopram tablets USP 40MG	$150.0K	3
Escitalopram tablets USP 5 MG	$100.0K	2
Fenofibrate capsules USP 134 MG	$100.0K	2
Citalopram tablets USP 20MG	$93.6K	2
Montelukast sodium chewable	$82.9K	2
Roweepra 500 MG	$79.6K	2
Fenofibrate capsules, USP 134 MG	$50.0K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Citalopram	CNS & Psychiatric	$1.6M	31	0.6%	14
2	Escitalopram	CNS & Psychiatric	$1.3M	26	0.7%	10
3	Minocycline	Advanced Antibiotics	$450.0K	9	2.0%	5

Torrent Pharma Inc Importer EIN 36-4547412 imports 3 pharmaceutical products across 2 categories into United States totaling $3.3M.

Torrent Pharma Inc Importer EIN 36-4547412 — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Torrent Pharma Inc., identified by Importer EIN 36-4547412, is a pharmaceutical importer based in the United States. The company operates as a buyer, sourcing finished pharmaceutical formulations from international suppliers for distribution within the U.S. market. Headquartered at 150 Allen Road, Basking Ridge, NJ 07920, Torrent Pharma Inc. is a subsidiary of Torrent Pharmaceuticals Limited, a leading Indian pharmaceutical company. Torrent Pharmaceuticals Limited is renowned for its extensive portfolio in therapeutic areas such as cardiovascular, central nervous system, gastro-intestinal, and women's healthcare.

In the United States, Torrent Pharma Inc. plays a pivotal role in the pharmaceutical distribution network by importing and supplying a range of finished drug products. These products are intended for various segments of the U.S. healthcare system, including retail pharmacies, hospitals, and clinics. The company's operations are integral to ensuring the availability of essential medications sourced from international markets, thereby contributing to the diversity and competitiveness of the U.S. pharmaceutical supply chain.

2Distribution Network

Torrent Pharma Inc. maintains a centralized distribution facility at its headquarters in Basking Ridge, New Jersey. This strategic location provides efficient access to major transportation hubs, facilitating the timely importation and distribution of pharmaceutical products. The company's logistics capabilities are designed to manage a diverse product portfolio, ensuring compliance with U.S. regulatory standards and meeting the demands of various healthcare providers across the country.

While specific details regarding additional warehouse locations or distribution centers are not publicly disclosed, Torrent Pharma Inc.'s operations are structured to support nationwide distribution. The company's logistics infrastructure is equipped to handle the complexities of importing finished pharmaceutical formulations, including adherence to FDA regulations and quality control measures. This setup enables Torrent Pharma Inc. to effectively serve the U.S. market, ensuring that imported medications are accessible to healthcare providers and patients nationwide.

3Industry Role

Torrent Pharma Inc. functions primarily as a pharmaceutical importer and distributor within the United States. By sourcing finished pharmaceutical formulations from international suppliers, particularly from its parent company, Torrent Pharmaceuticals Limited, it plays a crucial role in enhancing the diversity and competitiveness of the U.S. pharmaceutical market. The company's activities support the availability of a wide range of medications, contributing to the overall efficiency and resilience of the U.S. healthcare system.

In the U.S. pharmaceutical supply chain, Torrent Pharma Inc. serves as an intermediary between foreign manufacturers and domestic healthcare providers. Its operations ensure that imported pharmaceutical products meet the stringent standards set by U.S. regulatory bodies, including the FDA. By maintaining compliance with these regulations, Torrent Pharma Inc. upholds the integrity of the U.S. drug supply, ensuring that imported medications are safe, effective, and of high quality.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Torrent Pharma Inc Importer EIN 36-4547412

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Torrent Pharma Inc. demonstrates a high degree of sourcing concentration, with all its pharmaceutical imports originating from a single supplier: Torrent Pharmaceuticals Limited. This exclusive sourcing strategy results in a total import value of $3.3 million USD across 66 shipments, encompassing 27 unique formulations. The top three imported products—Citalopram, Escitalopram, and Minocycline—account for the majority of the import value, indicating a focused product portfolio.

The reliance on a single supplier can present both strategic advantages and potential risks. On the positive side, this concentration may lead to streamlined operations, simplified logistics, and potentially favorable terms due to the volume of business with Torrent Pharmaceuticals Limited. However, such dependency also exposes Torrent Pharma Inc. to risks associated with supply chain disruptions, regulatory changes affecting the supplier, or any operational challenges faced by Torrent Pharmaceuticals Limited. To mitigate these risks, it would be prudent for Torrent Pharma Inc. to consider diversifying its supplier base and exploring alternative sources for its pharmaceutical imports.

The shipment data reveals a consistent pattern of imports from Torrent Pharmaceuticals Limited, suggesting a stable and ongoing relationship. This stability is crucial for maintaining a reliable supply of pharmaceutical products to the U.S. market. Nonetheless, the absence of alternative suppliers underscores the importance of proactive risk management strategies to ensure continuity of supply and to safeguard against potential disruptions in the supply chain.

Supply Chain Resilience

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which governs the importation, manufacturing, and distribution of drugs within the U.S. This legislation ensures that all drugs, including those imported from foreign countries, meet the necessary standards for safety, efficacy, and quality.

The FDA's regulatory framework for pharmaceutical imports includes several key components:

Registration and Listing: Foreign drug establishments must register with the FDA and list all their drug products intended for import into the U.S. market. This process ensures that the FDA is aware of all drugs entering the country and can monitor their compliance with U.S. regulations.

Import Procedures: Importers are required to file an entry notice and an entry bond with U.S. Customs and Border Protection (CBP) when offering a drug for import. The FDA reviews these entries to determine the admissibility of the products, ensuring they meet all regulatory requirements.

Compliance and Enforcement: The FDA conducts inspections and examinations of imported drugs to verify compliance with the FD&C Act. Products that do not meet FDA standards may be refused entry into the U.S. market.

Frequently Asked Questions — Torrent Pharma Inc Importer EIN 36-4547412

What products does Torrent Pharma Inc Importer EIN 36-4547412 import from India?

Torrent Pharma Inc Importer EIN 36-4547412 imports 3 pharmaceutical products across 2 categories. Top imports: Citalopram ($1.6M), Escitalopram ($1.3M), Minocycline ($450.0K).

Who supplies pharmaceuticals to Torrent Pharma Inc Importer EIN 36-4547412 from India?

Torrent Pharma Inc Importer EIN 36-4547412 sources from 1 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (100.0% of imports, $3.4M).

What is Torrent Pharma Inc Importer EIN 36-4547412's total pharmaceutical import value?

Torrent Pharma Inc Importer EIN 36-4547412's total pharmaceutical import value from India is $3.3M, based on 66 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Torrent Pharma Inc Importer EIN 36-4547412 focus on?

Torrent Pharma Inc Importer EIN 36-4547412 imports across 2 categories. The largest: CNS & Psychiatric (86.4%), Advanced Antibiotics (13.6%).

Get Full Torrent Pharma Inc Importer EIN 36-4547412 Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Torrent Pharma Inc Importer EIN 36-4547412

Torrent Pharma Inc Importer EIN 36-4547412 — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Torrent Pharma Inc Importer EIN 36-4547412?

What Formulations Does Torrent Pharma Inc Importer EIN 36-4547412 Import?

What Products Does Torrent Pharma Inc Importer EIN 36-4547412 Import?

Top Products by Import Value

Torrent Pharma Inc Importer EIN 36-4547412 Therapeutic Categories — 2 Specializations